In the latest close session, Amgen (AMGN) was up +1.88% at $297.29. The stock outpaced the S&P 500's daily gain of 0.38%. Meanwhile, the Dow experienced a rise of 0.24%, and the technology-dominated ...

The U.S. Court of Appeals for the Third Circuit issued a precedential opinion in a case arising out of a somewhat obscure ...

Lipid management for woman requires personalized care that considers sex-specific conditions across the reproductive lifespan ...

Wesbanco Bank just pumped up its Amgen stock by 23.2%, scooping up over 64,000 shares worth nearly $20 million. This ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

During a live event, Gary J. Schiller, MD, explored the outcomes of the phase 1/2 trial of tagraxofusp-erzs in patients with ...

Sandoz is introducing Wyost (denosumab-bbdz) and Jubbonti (denosumab-bbdz, the first and only interchangeable FDA-approved ...

Amgen Manufacturing Limited LLC has received the U.S. Environmental Protection Agency’s Energy Star certification for its facility in Juncos, Puerto Rico, placing it among the most energy-efficient ...

Amgen remains a top contender for value investors looking to buy quality at a discount. The biotech giant boasts a Value ...

Bachleda, PharmD, MBA appointed as independent member of the Board of Directors; David Shook, MD appointed as Chief Medical Officer, Mark Meltz, JD as General Counsel and ...

Today, Benzinga's options scanner spotted 13 options trades for Amgen. This is not a typical pattern. The sentiment among ...